£109.82

This is the most expensive it has ever been. Walk away.

£110 today · previous high £110 · all-time low £108

Springer TRAIL, Fas Ligand, TNF and TLR3 in Cancer: 12 (Resistance to Targeted Anti-Cancer Therapeutics, 12)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£109.82 £107.82 £108.25 £108.69 £109.13 £109.57 £110.00 26 July 2026 10 August 2026 25 August 2026 09 September 2026 25 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 2 price levels

Days at Price
Current Price
61 days 1 day · current 0 15 31 46 61 £108 £110 Days at Price

Price Analysis

Most common price: £108 (61 days, 98.4%)

Price range: £108 - £110

Price levels: 2 different prices over 62 days

Description

This volume provides the current understanding of death receptor's/TLR3 signaling regulation in cancer. Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy. But an increasing body of evidence suggests that some of these receptors may also contribute to tumorigenesis, or that new players such as TLR3 may be targeted for cancer therapy due to their ability to behave like death receptors.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
12 August 2018
Listed Since
13 August 2018

Barcode

No barcode data available

Similar Products You Might Like

Tumor Necrosis Factor: Methods and Protocols: 98 (Methods in Molecular Medicine, 98)
95% match

Tumor Necrosis Factor: Methods and Protocols: 98 (Methods in Molecular Medicine, 98)

Humana

£84.82 24 Sep 2026
Progress in Cancer Immunotherapy - Springer Medical Research
95% match

Progress in Cancer Immunotherapy - Springer Medical Research

Springer

£110.37 05 Oct 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
94% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
IL-1 in Cancer and Inflammation - Academic Press Medical Book
94% match

IL-1 in Cancer and Inflammation - Academic Press Medical Book

Elsevier

£125.39 02 Oct 2026
Cancer and Autoimmunity (Autoanitbody Library)
94% match

Cancer and Autoimmunity (Autoanitbody Library)

Elsevier

£87.68 24 Sep 2026
Advances in TNF Family Research: Proceedings of the 12th International TNF Conference, 2009: 691 (Advances in Experimental Medicine and Biology, 691)
94% match

Advances in TNF Family Research: Proceedings of the 12th International TNF Conference, 2009: 691 (Advances in Experimental Medicine and Biology, 691)

Springer

£95.58 11 Aug 2026
Inflammation and Cancer Methods Protocols Volume 2 - Molecular Analysis
94% match

Inflammation and Cancer Methods Protocols Volume 2 - Molecular Analysis

Humana

£127.01 06 Oct 2026
Cancer Immunosurveillance: Methods and Protocols - Vol. 1884
94% match

Cancer Immunosurveillance: Methods and Protocols - Vol. 1884

Humana

£108.33 02 Oct 2026
Targeted Cancer Immune Therapy
94% match

Targeted Cancer Immune Therapy

Springer

£143.98 15 Aug 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
94% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£148.21 13 Oct 2026
Innate Immune Regulation and Cancer Immunotherapy - Springer
94% match

Innate Immune Regulation and Cancer Immunotherapy - Springer

Springer

£113.76 05 Oct 2026
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
94% match

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Springer

£76.07 18 Sep 2026
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
94% match

Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives

Elsevier

£94.39 17 Sep 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
94% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)

Humana

£92.38 11 Sep 2026
Interleukins in Cancer Biology: Their Heterogeneous Role
94% match

Interleukins in Cancer Biology: Their Heterogeneous Role

Elsevier

£62.35 12 Sep 2026
TRAIL, Fas Ligand, TNF and TLR3 in Cancer: 12 (Resistance to Targeted Anti-Cancer Therapeutics, 12)
94% match

TRAIL, Fas Ligand, TNF and TLR3 in Cancer: 12 (Resistance to Targeted Anti-Cancer Therapeutics, 12)

Springer

£103.81 22 Aug 2026
Immune Receptors: Methods and Protocols - Molecular Biology
94% match

Immune Receptors: Methods and Protocols - Molecular Biology

Humana

£101.40 01 Oct 2026
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
94% match

Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)

Elsevier

£73.99 23 Sep 2026
Inflammation and Immunity in Cancer
94% match

Inflammation and Immunity in Cancer

Springer

£189.98 24 Sep 2026
Humana Autoimmunity: Methods and Protocols - 900 Series
94% match

Humana Autoimmunity: Methods and Protocols - 900 Series

Humana

£102.47 02 Oct 2026
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
94% match

Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)

CRC Press

£170.01 23 Sep 2026
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
94% match

Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)

Humana

£99.33 20 Oct 2026
Advances in TNF Family Research: Proceedings of the 12th International TNF Conference, 2009: 691 (Advances in Experimental Medicine and Biology, 691)
94% match

Advances in TNF Family Research: Proceedings of the 12th International TNF Conference, 2009: 691 (Advances in Experimental Medicine and Biology, 691)

Springer

£203.36 11 Aug 2026
Cytotoxic T-Cells: Methods and Protocols: 1186 (Methods in Molecular Biology, 1186)
94% match

Cytotoxic T-Cells: Methods and Protocols: 1186 (Methods in Molecular Biology, 1186)

Humana

£80.67 08 Oct 2026